These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 20182882)

  • 1. Intravitreal triamcinolone acetonide versus bevacizumab therapy for macular edema associated with branch retinal vein occlusion.
    Byun YJ; Roh MI; Lee SC; Koh HJ
    Graefes Arch Clin Exp Ophthalmol; 2010 Jul; 248(7):963-71. PubMed ID: 20182882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective comparisons of intravitreal injections of triamcinolone acetonide and bevacizumab for macular oedema due to branch retinal vein occlusion.
    Higashiyama T; Sawada O; Kakinoki M; Sawada T; Kawamura H; Ohji M
    Acta Ophthalmol; 2013 Jun; 91(4):318-24. PubMed ID: 22132711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal triamcinolone acetonide compared with bevacizumab for the treatment of patients with macular edema secondary to central retinal vein occlusion.
    Gokce G; Sobaci G; Durukan AH; Erdurman FC
    Postgrad Med; 2013 Sep; 125(5):51-8. PubMed ID: 24113663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of injection of intravitreal drugs with standard care in macular edema secondary to branch retinal vein occlusion.
    Lee K; Jung H; Sohn J
    Korean J Ophthalmol; 2014 Feb; 28(1):19-25. PubMed ID: 24505197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal triamcinolone acetonide injection for macular edema due to central retinal vein occlusion persisting despite multiple intravitreal bevacizumab injections.
    Alshareef RA; Garg SJ; Hsu J; Vander J; Park C; Spirn MJ
    J Ocul Pharmacol Ther; 2014 Aug; 30(6):512-6. PubMed ID: 24828198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of natural course, intravitreal triamcinolone, and intravitreal bevacizumab for treatment of macular edema secondary to branch retinal vein occlusion.
    Kwon SI; Kim YW; Bang YW; Lee JY; Park IW
    J Ocul Pharmacol Ther; 2013 Feb; 29(1):5-9. PubMed ID: 23237542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema.
    Bae JH; Lee CS; Lee SC
    Retina; 2011 Jan; 31(1):111-8. PubMed ID: 20856170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema secondary to branch retinal vein occlusion.
    Cheng KC; Wu WC; Chen KJ
    Eye (Lond); 2009 Nov; 23(11):2023-33. PubMed ID: 19798117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between intravitreal bevacizumab and triamcinolone for macular edema secondary to branch retinal vein occlusion.
    Kim JY; Park SP
    Korean J Ophthalmol; 2009 Dec; 23(4):259-65. PubMed ID: 20046685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of three different intravitreal treatment modalities of macular edema due to branch retinal vein occlusion.
    Cekiç O; Cakır M; Yazıcı AT; Alagöz N; Bozkurt E; Faruk Yılmaz O
    Curr Eye Res; 2010 Oct; 35(10):925-9. PubMed ID: 20858114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The variable efficacy of intravitreal bevacizumab and triamcinolone acetonide for cystoid macular edema due to radiation retinopathy.
    Bakri SJ; Larson TA
    Semin Ophthalmol; 2015 Jul; 30(4):276-80. PubMed ID: 24251435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bevacizumab for macular edema secondary to retinal vein occlusion: a systematic review and meta-analysis.
    Lu Y; Su L; Xu X
    J Ocul Pharmacol Ther; 2013 Oct; 29(8):702-8. PubMed ID: 23746130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of branch retinal vein occlusion induced macular edema in treatment-naïve cases with a single intravitreal triamcinolone or bevacizumab injection.
    Chen CH; Chen YH; Wu PC; Chen YJ; Lee JJ; Liu YC; Kuo HK
    Chang Gung Med J; 2010; 33(4):424-35. PubMed ID: 20804672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal bevacizumab versus triamcinolone acetonide for macular edema due to branch retinal vein occlusion: a matched study.
    Hou J; Tao Y; Jiang YR; Li XX; Gao L
    Chin Med J (Engl); 2009 Nov; 122(22):2695-9. PubMed ID: 19951598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of early injection of intravitreal triamcinolone acetonide (IVTA) versus delayed injection for macular edema resulting from retinal vein occlusion].
    Saleh M; Gaucher D; Letsch J; Bourcier T; Speeg-Schatz C
    J Fr Ophtalmol; 2011 Jun; 34(6):355-61. PubMed ID: 21652108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation.
    Cakir M; Dogan M; Bayraktar Z; Bayraktar S; Acar N; Altan T; Kapran Z; Yilmaz OF
    Retina; 2008 Mar; 28(3):465-72. PubMed ID: 18327140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined treatment of intravitreal bevacizumab and intravitreal triamcinolone in patients with retinal vein occlusion: 6 months of follow-up.
    Ehrlich R; Ciulla TA; Moss AM; Harris A
    Graefes Arch Clin Exp Ophthalmol; 2010 Mar; 248(3):375-80. PubMed ID: 19898827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the short-term effects of intravitreal triamcinolone acetonide and bevacizumab injection for diabetic macular edema.
    Song JH; Lee JJ; Lee SJ
    Korean J Ophthalmol; 2011 Jun; 25(3):156-60. PubMed ID: 21655039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in aqueous cytokines after intravitreal triamcinolone versus bevacizumab for macular oedema in branch retinal vein occlusion.
    Sohn HJ; Han DH; Lee DY; Nam DH
    Acta Ophthalmol; 2014 May; 92(3):e217-24. PubMed ID: 23889803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.